ICD-10-CM Billable Code

B41.8

Other forms of paracoccidioidomycosis

Clinical Classification Guidelines

Medical Intelligence & Overview

Paracoccidioidomycosis is a fungal infection primarily affecting the lungs and skin, caused by the Paracoccidioides species. While the most common form involves respiratory and mucocutaneous tissues, there are rarer, more diverse presentations. ICD-10 code B41.8 refers to 'Other forms of paracoccidioidomycosis,' highlighting these less typical manifestations. Recognizing these forms is important for heightened awareness and appropriate management of this endemic fungal disease, primarily found in South and Central America.

Causes & Symptoms

Clinical Causes: Inhalation of airborne spores from the Paracoccidioides fungus, which resides in soil, particularly in rural or agricultural environments Endemic exposure in regions with high prevalence, often due to close contact with infected soil Potential reactivation of a latent infection in immunocompromised individuals Limited evidence suggests possible transmission through direct contact with infected tissues, though inhalation remains primary

Key Symptoms: Localized or disseminated skin lesions, which may include ulcers, nodules, or plaques Lymphadenopathy, often enlarged lymph nodes that may be tender Organ-specific symptoms depending on distribution, such as liver or spleen involvement Fungal dissemination leading to systemic symptoms like fever, weight loss, and fatigue In some cases, involvement of bones, mucous membranes, or other tissues may result in varied clinical presentations Less common presentations include ocular or neurological symptoms, depending on the sites affected

Diagnostic & Treatment

Diagnosis Path: Clinical evaluation of symptoms and patient history, especially exposure to endemic areas Direct microscopic examination of tissue samples or body fluids revealing characteristic yeast forms with multiple budding, resembling a captain's wheel Histopathological analysis confirming fungal structures and tissue reaction Culture of the fungus from clinical specimens, though this can be slow Serological testing such as complement fixation or immunodiffusion tests to detect specific antibodies Imaging studies like chest X-rays or CT scans may help assess pulmonary or other organ involvement

Treatment Protocols: Sulfonamides, especially for mild cases Itraconazole, a preferred azole antifungal for extensive or disseminated disease Trimethoprim-sulfamethoxazole (TMP-SMX) for moderate to severe cases Amphotericin B in resistant or life-threatening cases, usually in hospital settings Supportive care to address symptoms and complications, including wound care for skin lesions Long-term therapy is often necessary to prevent relapse, sometimes extending for several months or years depending on response

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B41.8 a billable ICD-10 code?
Yes, B41.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B41.8?
Clinical documentation must specify the nature of Other forms of paracoccidioidomycosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

forms paracoccidioidomycosis